ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 70 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 3.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $373,860 | -19.8% | 124,620 | 0.0% | 0.00% | – |
| Q2 2023 | $466,079 | +55.5% | 124,620 | +39.2% | 0.00% | – |
| Q1 2023 | $299,825 | -26.9% | 89,500 | +4.9% | 0.00% | – |
| Q4 2022 | $410,293 | -10.0% | 85,300 | +6.5% | 0.00% | – |
| Q3 2022 | $456,000 | -19.9% | 80,100 | 0.0% | 0.00% | – |
| Q2 2022 | $569,000 | -1.6% | 80,100 | 0.0% | 0.00% | – |
| Q1 2022 | $578,000 | -19.0% | 80,100 | +0.3% | 0.00% | – |
| Q4 2021 | $714,000 | -78.9% | 79,900 | -17.0% | 0.00% | -100.0% |
| Q3 2021 | $3,376,000 | +75.0% | 96,288 | +7.2% | 0.00% | 0.0% |
| Q2 2021 | $1,929,000 | +66.1% | 89,800 | +377.6% | 0.00% | 0.0% |
| Q1 2021 | $1,161,000 | +118.6% | 18,802 | +48.0% | 0.00% | – |
| Q4 2020 | $531,000 | – | 12,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $4,712,400 | 33.11% |
| BML Capital Management, LLC | 2,236,239 | $8,363,534 | 7.52% |
| TANG CAPITAL MANAGEMENT LLC | 3,026,455 | $11,318,942 | 1.67% |
| Stonepine Capital Management, LLC | 752,088 | $2,812,809 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $9,296,286 | 0.96% |
| CM Management, LLC | 250,000 | $935 | 0.91% |
| EcoR1 Capital, LLC | 6,995,861 | $26,164,520 | 0.64% |
| Cormorant Asset Management, LP | 1,547,181 | $5,786,457 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 501,537 | $1,875,748 | 0.31% |
| Auour Investments LLC | 177,000 | $661,980 | 0.28% |